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1. Introduction 
Concanavalin A (Con A) has been reported to 
affect plasma membrane-bound enzyme activities 
in lymphocytes [ 1,2], fat cells [3,4] and liver [3,5,6]. 
In particular it has been shown that Con A exerts 
a hormone-like effect on adenylate cyclase [3], and 
that it is able to act on plasma membrane-bound 
enzymes by a mechanism probably related to a 
modification of cyclic AMP levels [6] . The mito- 
genicity of Con A [7] has been recently connected 
with its alleged ability to affect cyclic AMP concentra- 
tion acting by an insulin-like mechanism on adenylate 
cyclase [3,8,9], a hypothesis that we were unable to 
support by closely related experiments [6]. 
On the basis of the experimental data reviewed 
above we investigated the possible mechanism by 
which Con A is able to affect cyclic AMP level; 
considering both adenylate cyclase and cyclic AMP- 
phosphodiesterase activity of isolated rat liver plasma 
membrane. The results obtained suggest hat Con A 
acts, at low concentrations, by inhibiting a plasma 
membrane-bound high affinity cyclic AMP-phospho- 
diesterase. 
2. Materials and methods 
Liver plasma membranes were isolated from male 
Wistar rats according to Ray [lo] as previously 
reported [ 111. 
Adenylate cyclase was assayed as previously 
described [ 121 by measuring cyclic AMP formed 
North-Holland Publishing Company - Amsterdam 
according to the method of Brown et al. [ 131 as 
previously reported [ 141. 
Cyclic AMP-phosphodiesterase was assayed 
basically by the two-step procedure of Thompson 
and Appleman [ 151 in a medium containing 40 mM 
Tris-HCl (pH 7.5), 5 mM MgCl,, 80- 120 pg membrane 
protein in a final volume of 0.6 ml [ 161, unless 
otherwise stated. 
Protein was estimated by the method of Lowry 
et al. [ 171, using bovine serum albumin as a standard. 
Con A was the twice-crystallized product from 
Miles-Yeda Ltd., Rehovot, Israel. Cyclic AMP 
(adenosine 3’,5’ monophosphoric acid) was from 
Boehringer, Mannheim, Germany. cr-D-Methylmanno- 
side was from Sigma, St. Louis, MO., USA. [8-3H] 
Adenosine-3’,5’-monophosphoric acid, ammonium 
salt (27 Ci/mmol) was obtained from the Radio- 
chemical Centre, Amersham, Bucks., UK. For the 
phosphodiesterase assay, freeze-dried 5’-nucleotidase 
from Crotalus adamanteus (BDH Chemicals, Poole, UK) 
and AC l-X2, 200-400 mesh, Cl- form resin (Bio- 
Rad Laboratories, Richmond, Cal., USA) were 
employed. 
3. Results 
The effect of different concentrations of Con A on 
adenylate cyclase activity of liver plasma membrane 
has been tested either in basal conditions or in the 
presence of hormonal activators of the cyclase activity 
like glucagon and prostaglandin E, [ 121. The lectin is 
able to stimulate signficantly adenylate cyclase activity 
(fig. 1) at low concentrations, while concentrations 
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Fig.1. Effect of Concanavalin A on the basal (a------ e), prostaglandin El (IO ~g/mi~stimulated fo--o) and 
glucagon (1 X IO-6 M)-stimulated (0 o) adenylate cyclase activity of rat liver plasma membranes. Membranes were 
preincubated 5 mm with or without Concanavalin A. Results are reported as pmoles cyclic AMP/mg protein per 5 min. Points 
are means of at least two separate xperiments carried out in duphcate, the standard error never exceeded 13% of the reported 
values. Analysis of variance of these data as a randomized-block experiment showed significant (KO.05) differences between 
the three treatments. 
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above 5 pg/ml progressively lead to the disappearance 
of the stimulatory effect, even if this decrease is not 
statistically significant. More dramatic results are 
obtained when Con A is tested in the presence of 
glucagdn or prostaglandin E, : the hormonal stimula- 
tion of the adenylate cyclase activity above its basal 
level is remarkably enhanced by the lectin. In the 
presence of Con A the effect of prostaglandin El on 
adenylate cyclase is almost doubled and glucagon 
effect increases by about .50%, at least up to 3 fig/ml 
of lectin. 
Cyclic AMP-dependent phosphodiesterase activity 
of liver plasma membrane was investigated, employing 
two different substrate concentrations, in order to test 
the low and high affinity component of the enzyme 
[ 16,18-201. Con A added in the range 0.1-40 
pg/ml (fig.2) produces a clear and significant inhibi- 
tory effect on the high affinity component (tested at 
1 X 1 O- 6 M cyclic AMP) while at higher lectin con- 
centrations a paradoxical stimulation, similar to the 
Con A effect on adipocyte adenylate cyclase [3], 
occurs. The low affinity component of cyclic AMP- 
phosphodiesterase (tested at 1 X 10-d M cyclic AMP) 
is essentially unaffected by low lectin concentrations, 
but at high levels (> 20 pg/ml) a stimulatory effect 
which parallels that seen for the high affinity compo- 
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Fig.3. Scatchard-type plot [ 211 of the effect of Concanavalin A (25 rg/ml) on membrane-bound cyclic AMP-phosphodiesterase. 
Each point is the mean of triplicate determinations. C is given as nmoles of cylic AMP and V is expressed as nmoles cyclic AMP 
hydrolyzed/mg protein per 10 min. Membranes were preincubated 5 min with (o---- o) or without (0 -0) 
Concanavalin A before the experiment. The final reaction volume of these experiments was 0.2 ml. Intercepts values were 
calculated by linear regression. The two intercepts on the x axis for the high affinity component are significantly different 
(P<O.OS) as assessed by analysis of variance of the regression lines. 
Fig.2. Concanavalin A effect on cyclic AMP-dependent phosphodiesterase (CAMP-PDE). Results are reported as nmoles cyclic 
AMP hydrolyzed/mg protein per 10 min. Substrate concentration was 1 X lop4 M (o----- 0) or 1 X 10m6 M (o-o). 
Plasma membranes were preincubated 30 min at 30°C with or without the lectin, in the reaction medium before adding the 
substrate. Each point is the mean of four duplicate experiments carried out on different membrane preparations; the average 
standard error never exceeded 15% of the reported values. Analysis of variance carried out for the range O-40 pg/ml of 
Concanavalin A sug ests that the reported effect is statistically significant WO.05) for CAMP 1 X 10e6 M but not significant 
for CAMP 1 X 10 -l,. 
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Table 1 
Effects of concanavalin A, orD-methylmannoside and theophylline on cyclic AMP-phosphodiesterase of liver plasma membranes 
Cyclic AMP 1 X lop4111 Cyclic AMP 1 X lop6 M 
Exp. I 
Control 
Concanavalin A 10 bg/ml 
a-D-Methylmannoside 8 mM 
Concanavalin A 10 fig/ml + ol-Dmethylmannoside 8 mM 
Exp. 2 
Control 
Concanavalin A 10 Mg/ml 
Theophylline 5 mM 
Concanavalin A 10 pg/ml + theophylline 5 mM 
_ 0.32 + 0.06 
_ 0.18 + 0.02a 
_ 0.32 * 0.06 
_ 0.23 * 0.03a>b 
26.6 k 3.8 0.32 + 0.06 
30.4 r 4.5 0.21 * 0.04a 
14.9 i- 2.3a 0.33 i: 0.05 
18.5 + 2.7a,b,c 0.24 * 0.03a 
Enzyme activity is reported as nmoles cyclic AMP hydrolyzed f S.E./mg protein per 10 min. Membranes were preincubated with 
or without the substances under investigation as reported in fig.2. Results are means of duplicate experiments carried out on five 
different membrane preparations. Student’s t test (~10) was performed with respect to controls (aP<O.OOl); with respect 
Concanavalin A (bE’<O.OO1); with respect to theophylline (cP<O.Ol); all other differences being statistically not significant. 
to 
nent was observed. A kinetic analysis of the effect of 
Con A on membrane-bound cyclic AMP-phosphodi- 
esterase (fig.3) shows that the lectin behaves as a non- 
competitive inhibitor. The following kinetic constants 
were obtained from the non-linear Scatchard plot extra- 
polated: for the control KM 1 and KM2 were 2.8 and 
41.9 PM respectively; for Con A-treated membranes the 
values were 2.3 and 47.6 PM. Control Vmaxl and 
V max2 were 2.16 and 17.1, for Con A-treated mem- 
branes Vmaxl was 1.5 and Vmax2 14.8 nmol/mg 
protein/l 0 min. Thus the main effect is that the Vmax 
of the high affinity component was reduced by Con A. 
We have also observed that Con A did not affect the 
activity of cyclic AMP-phosphodiesterase assayed on a 
soluble fraction obtained after a 30 min centrifugation 
at 100 000 g of a liver homogenate, when the substrate 
concentration was varied between 0.04 and 12.5 /IM 
(not shown). 
That the Con A inhibition of the high affinity 
cyclic AMP-phosphodiesterase is dependent on the 
specific binding of the lectin to plasma membrane- 
bound saccharide groups is clearly demonstrated by 
the results reported in table 1, which show that the 
Con A effect is partially prevented by a-D-methyl- 
mannoside, a saccharide which specifically binds to 
the active site of the lectin [7], but does not itself 
affect membrane-bound enzyme activities [6]. In 
addition table 1 shows a clear discrepancy between 
the effects of Con A and theophylline, a known phos- 
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phodiesterase inhibitor [ 1 S] , on the two components 
of the cyclic AMP-dependent phosphodiesterase; the 
low affinity component is inhibited by the methyl- 
xanthine but it is insensitive to Con A, whereas 
essentially the reverse is true for the high affinity 
component. The latter result gives further support to 
the differential response of the two phosphodiesterase 
components to Con A. 
4. Discussion 
Our results are at variance with published observa- 
tions [3] concerning a negative modulation of adipocyte 
plasma membrane adenylate cyclase in the range of 
low Con A concentrations (up to 30 pg/ml); con- 
versely a paradoxical effect of Con A in the high 
range of lectin concentrations (40 to 200 pg/ml) has 
been noticed in our experiments on cyclic AMP- 
dependent phosphodiesterase. Furthermore the 
results point to a possible differential separation 
between low and high affinity cyclic AMP-phospho- 
diesterase components on the basis of their sensitivity 
to Con A in the range of low lectin concentrations; 
such a result, even if with a reversed relationship to 
the enzyme activity, has already been shown in liver 
plasma membranes for insulin sensitivity of cyclic 
AMP-phosphodiesterase [ 161. 
From the data presented so far it is possible to 
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assume that Con A acts primarily, at low concentra- 
tions, as a non-competitive inhibitor of a plasma 
membrane-bound high affinity cyclic AMP-dependent 
phosphodiesterase which has been recently described 
[19,20,22] . Therefore the stimulation exerted by 
Con A on the basal adenylate cyclase activity as well, 
as its potentiation of glucagon and prostaglandin E, 
stimulation can probably be ascribed to the phospho- 
diesterase inhibition; such a hypothesis is well 
supported by the complete insensitivity of the high 
affinity phosphodiesterase to theophylline, a substance 
which is also present during adenylate cyclase assay: 
this obviously means that the Con A effect is a direct 
one and it is not a misinterpretation due to the 
presence of theophylline. 
These results which together indicate that Con A 
acts at the plasma membrane level increasing cyclic 
AMP concentration rule out, at least for liver, a 
possible insulin-like effect of the lectin and fit well 
with previous reports concerned with hormone and 
Con A sensitivity of membrane-bound enzymes 
[6,23-251. 
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